|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/12 | |
| A61K 39/39 | |||
| A61P 31/14 |
| (11) | Patento numeris | 2950816 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14702282.6 |
| Europos patento paraiškos padavimo data | 2014-02-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-12-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-07-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/052111 |
| Data | 2014-02-04 |
| (87) | Numeris | WO 2014/118385 |
| Data | 2014-08-07 |
| (30) | Numeris | Data | Šalis |
| 20130175 | 2013-02-04 | NO |
| (72) |
ROBERTSEN, B rre., NO
CHANG, Chia Jung., NO
|
| (73) |
Schweitzer Biotech Company Ltd.,
4F., No.16, Ln. 120, Sec. 1, Neihu Rd. Neihu Dist., Taipei, 11493,
TW
|
| (54) | THE USE OF DNA SEQUENCES ENCODING AN INTERFERON AS VACCINE ADJUVANTS |
| THE USE OF DNA SEQUENCES ENCODING AN INTERFERON AS VACCINE ADJUVANTS |